Increased microvessel density in mucinous compared with malignant serous and benign tumours of the ovary

British Journal of Cancer

Volumn 77, Issue 12, 1998, Pages 2204-2209

  Orre, M ^a   Lotfi Miri, M ^a   Mamers, P ^a   Rogers, P A W ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Angiogenesis; Benign; Microvessel density; Mucinous; Ovarian cancer; Serous

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; CAPILLARY DENSITY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MICROVASCULATURE; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; TUMOR VASCULARIZATION;

EID: 0031779574     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.367     Document Type: Article

References (26)

1. Chaubal A, Paetau A, Zoltick P and Miettinen M (1994) CD34 immunoreactivity in nervous system tumours. Acta Neuropathol (Berl) 88: 454-458
2. Dameron KM, Volpert OV, Tainsky MA and Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Science 265: 1582-1584
3. Deligdisch L (1994) Ovarian benign epithelial tumors. In Atlas of Ovarian Tumors, Deligdisch L, Altchek A and Cohen C (eds) pp. 65-76. Igaku-Shoin: New York
4. DeLisser HM, Newman PJ and Albelda SM (1994) Molecular and functional aspects of PECAM-1/CD31. Immunol Today 15: 490-495
5. Fay PJ (1993) Factor VIII structure and function. Thromb Haemost 70: 63-67
6. Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43: 175-203
7. Fujita M, Enomoto T, Inoue M, Tanizawa O, Ozaki M, Rice JM and Nomura T (1994) Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary. Jpn J Cancer Res 85: 1247-1256
8. Gasparini G, Bonoldi E, Viale G, Verderio P, Boracchi P, Panizzoni GA, Radaelli U, Di Bacco A, Guglielmi RB and Bevilacqua P (1996) Prognostic and predictive value of tumour angiogenesis in ovarian carcinomas. Int J Cancer 69: 205-211
9. Hart W (1992) Pathology of malignant and borderline (low malignant potential) epithelial tumors of ovary. In Gynecologic Oncology, Coppleson M, Monaghan J, Morrow C and Tattersall M (eds) pp. 863-887. Churchill Livingstone: Edinburgh
10. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML and Merino MJ (1995) Tumor angiogenesis in advanced stage ovarian carcinoma (see comments). Am J Pathol 147: 33-41
11. Krause DS, Fackler MJ, Civin CI and May WS (1996) CD34: structure, biology, and clinical utility. Blood 87: 1-13
12. Kristensen GB and Tropé C (1997) Epithelial ovarian carcinoma. Lancet 349: 113-117
13. Kuzu I, Bicknell R, Harris AL, Jones M, Gatter KC and Mason DY (1992) Heterogeneity of vascular endothelial cells with relevance to diagnosis of vascular tumours. J Clin Pathol 45: 143-148
14. Liotta LA, Kleinerman J and Saidel GM (1974) Quantitative relationships of intravascular tumor cells, tumor vessels, and pulmonary metastases following tumor implantation. Cancer Research 34: 997-1004
15. Liotta LA, Steeg PS and Stetler-Stevenson WG (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64: 327-336
16. McCulloch P, Choy A and Martin L (1995) Association between tumour angiogenesis and tumour cell shedding into effluent venous blood during breast cancer surgery. Lancet 346: 1334-1335
17. Rak JW, St Croix BD and Kerbel RS (1995a) Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. Anticancer Drugs 6: 3-18
18. Rak J, Mitsuhashi Y, Bayko L, Filmus J, Shirasawa S, Sasazuki T and Kerbel RS (1995b) Mutant ras oncogenes upregulate VEGF/VPF expression: implications for induction and inhibition of tumor angiogenesis. Cancer Res 55: 4575-4580
19. Reynolds K, Farzaneh F, Collins WP, Campbell S, Bourne TH, Lawton F, Moghaddam A, Harris AL and Bicknell R (1994) Association of ovarian malignancy with expression of platelet-derived endothelial cell growth factor. J Natl Cancer Inst 86: 1234-1238
20. Schlingemann RO, Rietveld FJ, Kwaspen F, van de Kerkhof PC, de Waal RM and Ruiter DJ (1991) Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. Am J Pathol 138: 1335-1347
21. Sheid B (1992) Angiogenic effects of macrophages isolated from ascilic fluid aspirated from women with advanced ovarian cancer. Cancer Lett 62: 153-158
22. Toi M, Kashitani J and Tominaga T (1993) Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int J Cancer 55: 371-374
23. van Diest PJ, Zevering JP, Zevering LC and Baak JP (1995) Prognostic value of microvessel quantitation in cisplatin treated FIGO 3 and 4 ovarian cancer patients. Pathol Res Pract 191: 25-30
24. Visscher DW, Lawrence WD, Boman S (1994) Angiogenesis in breast carcinoma - clinicopathologic relevance and potential use as a quantifiable surrogate endpoint biomarker. J Cell Biochem Suppl 19: 146-152
25. Weidner N (1995) Intratumor microvessel density as a prognostic factor in cancer [comment]. Am J Pathol 147: 9-19
26. Weidner N, Semple JP, Welch WR and Folkman J (1991) Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 324: 1-8